» Authors » Insara Jaffer Sathick

Insara Jaffer Sathick

Explore the profile of Insara Jaffer Sathick including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 107
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Abramson M, Sathick I, Knezevic A, Perales M, Jaimes E
Kidney360 . 2024 Oct; PMID: 39446483
Background: Acute kidney injury (AKI) is a common complication of allogeneic hematopoietic cell transplantation (allo-HCT) that increases the risk of mortality. In contrast, higher diversity of intestinal microbiota at the...
2.
Pak W, Brumwell N, Kabel C, Gutgarts V, Sathick I, Mailankody S, et al.
Kidney Med . 2024 Aug; 6(8):100856. PMID: 39100867
Chimeric antigen receptor (CAR) T-cell therapy against B-cell maturation antigen is a new treatment modality for relapsed or refractory multiple myeloma (MM). Patients with kidney failure and MM were excluded...
3.
Nasr S, Kudose S, Javaugue V, Harel S, Said S, Pascal V, et al.
Kidney Int . 2022 Dec; 103(3):616-626. PMID: 36581019
Monoclonal immunoglobulin light chain (LC) crystalline inclusions within podocytes are rare, poorly characterized entities. To provide more insight, we now present the first clinicopathologic series of LC crystalline podocytopathy (LCCP)...
4.
Javaugue V, Valeri A, Sathick I, Said S, Damgard S, Murray D, et al.
Kidney Int . 2022 May; 102(2):382-394. PMID: 35513122
The clinicopathologic characteristics and long-term outcome of non-hepatitis-associated cryoglobulinemic glomerulonephritis (CryoGN) are not well-defined and cases with undetectable serum cryoglobulin (seronegative CryoGN) have not been investigated. To resolve this, we...
5.
Barbar T, Sathick I
Adv Chronic Kidney Dis . 2022 Feb; 28(5):438-446.e1. PMID: 35190110
Tumor lysis syndrome (TLS) is an oncologic emergency due to massive tumor cell lysis with the release of large amounts of potassium, phosphate, and nucleic acids into the systemic circulation....
6.
Abramson M, Gutgarts V, Zheng J, Maloy M, Ruiz J, Scordo M, et al.
Clin J Am Soc Nephrol . 2021 Jun; 16(9):1318-1327. PMID: 34135023
Background And Objectives: AKI is a major complication of allogeneic hematopoietic stem cell transplantation, increasing risk of nonrelapse mortality. AKI etiology is often ambiguous due to heterogeneity of conditioning/graft versus...
7.
Yadav P, Sathick I, Leung N, Brown E, Cook M, Sanders P, et al.
Blood Cancer J . 2020 Mar; 10(3):28. PMID: 32127527
Myeloma cast nephropathy (MCN) is a common cause of severe renal impairment in multiple myeloma (MM). The level of free light chain (FLC) that causes MCN varies substantially and there...
8.
Gutgarts V, Sathick I, Zheng J, Politikos I, Devlin S, Maloy M, et al.
Biol Blood Marrow Transplant . 2020 Jan; 26(4):758-763. PMID: 31911259
Although cord blood transplantation (CBT) extends allograft access, patient comorbidities, chemoradiation, and nephrotoxic medications all contribute to acute kidney injury (AKI) risk. We analyzed AKI in adult myeloablative CBT recipients...
9.
Gonzalez Suarez M, Zhang P, Nasr S, Sathick I, Kittanamongkolchai W, Kurtin P, et al.
Kidney Int . 2019 Aug; 96(4):1005-1009. PMID: 31447055
Immunoglobulin light chain amyloidosis is the most frequent type of renal amyloidosis in the United States, accounting for 81% of cases. Accurate typing is crucial for early diagnosis and treatment...
10.
Sathick I, Zand L, Nasr S, Leung N
Clin Nephrol . 2018 Nov; 91(2):79-86. PMID: 30474593
Introduction: C3 glomerulonephritis (C3GN) is a form of proliferative glomerulonephritis characterized by dominant glomerular C3 deposition. There is currently no consensus guideline on therapy for this disease. Experience with corticosteroids...